NONOF | tickerfilter.com

Fundamental analysis

Profitability 0%

Dept financing 0%

Liquidity 0%

Performance 10%

Performance

5 Days

-3.16%

1 Month

3.16%

3 Months

1.62%

6 Months

1.62%

1 Year

1.62%

2 Year

1.62%

Key data

Stock price

$88.53

P/E Ratio

27.68

DAY RANGE

$86.39 - $88.60

EPS

N/A

52 WEEK RANGE

$77.95 - $94.05

52 WEEK CHANGE

$1.62

MARKET CAP

387.950 B

YIELD

1.68%

SHARES OUTSTANDING

0.000

DIVIDEND

N/A

EX-DIVIDEND DATE

N/A

NEXT EARNINGS DATE

N/A

BETA

0.00

PUBLIC FLOAT

N/A

AVERAGE 10 VOLUME

$21,436

AVERAGE 30 VOLUME

$100,839

Company detail

CEO: Lars F. Jørgensen
Region: US
Website: novonordisk.com
Employees: 54,400
IPO year: 1982

Issue type:
Market: OTCM
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing

Novo Nordisk A/S engages in the research, development, manufacture, and marketing of pharmaceutical products. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, and other chronic diseases. The Biopharmaceuticals segment offers products in areas of haemophilia, growth disorders, and hormone replacement therapy. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark.

NONOF - NOVO NORDISK A S